GRAMINEX L.L.C. expands its partnership with IDIPharma after clinical study publication.
SAGINAW, MICH.--(Business Wire / Korea Newswire) October 31, 2017 -- Graminex® LLC, producer of Non-Solvent Graminex® Flower Pollen Extracts™, is pleased to announce the expansion of its partnership with IDIPharma. After completion and publication of clinical studies supporting the use of Graminex® Flower Pollen Extract™ for Prostate Pain and Chronic Pelvic Pain (CCP), IDIPharma and Graminex® have agreed to expand clinical research on Graminex® Flower Pollen Extract™.
“Graminex® looks forward to expanding its relationship with IDIPharma, producer of DEPROX® 500 containing Non-Solvent Graminex® Flower Pollen Extract™. IDIPharma has proven its outstanding commitment to quality by delivering substantiated products to its customers,” stated Justin E Ritter, Regulatory Affairs.
“IDIPharma is committed to solving gynecological, urological and andrological problems by its continued scientific collaboration within the medical community. Deprox® 500, which contains Non-Solvent Graminex® Flower Pollen Extract™, was the first Italian Supplement strongly focused on prostatitis. Deprox® is supported by clinical studies that underline the distinctiveness of its formulation and its real effectiveness in regards to the long standing problems of prostatitis,” stated Dora Arena, Ph.D.
About Graminex® LLC
Graminex® LLC is the leading producer of natural and solvent free Graminex® Flower Pollen Extract™. Graminex® directly owns and manages more than 8,500 acres of farmland in Northwest Ohio. Graminex’s® active raw ingredients are grown and processed for use in the dietary supplement, pharmaceutical, food and skincare industries. Graminex® markets clinically supported Flower Pollen Extracts, focusing on prostate care, urinary care, menopausal support, and skin care. Partnered with its distributors, retailers and manufacturers, Graminex® products are sold in more than 44 countries.
About IDI Integratori Dietetic Italiana S.r.l.
IDIPharma is a pioneer and leader in the Italian phyto-market, focusing on urological diseases. Each year IDIPharma sponsors several Italian and European Urological Congresses to increase the awareness of Deprox® through urologists and publicizing results of clinical studies containing Non-Solvent Graminex® Flower Pollen Extracts™.
For further information please contact Graminex® LLC Public Relations, Colleen E. May at (419) 278-1023 or e-mail at email@example.com. You may also visit www.graminex.com.
IDI Integratori Dietetici Italiani S.r.l., Dora Arena, Ph.D. at 39.095.445392 or email at firstname.lastname@example.org You may also visit www.idipharma.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171030005045/en/
Colleen E. May
+1 (419) 278-1023
2-300 County Road C
Deshler, Ohio 43516
IDI Integratori Dietetici Italiani S.r.l.
Dora Arena, Ph.D.
Via G. Mameli 12
95020 ACI BONACCORSI (CT)
This is a news release distributed by Korea Newswire on behalf of this company.